---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-003597"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2023-01-19T23:59:59+00:00"
generated_at: "2026-06-20T13:11:05.004020+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on Jan 18, 2023 confirming full compliance with Listing Rule 5550(a)(2).
- Closing bid price of voting common stock was $1.00 or higher for ten consecutive days (Jan 3-17, 2023).
- Compliance removes risk of delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-23-003597
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2023-01-19T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/0001213900-23-003597-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/ea171850-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-003597
- JSON: https://secwatch.observer/filing/0001213900-23-003597.json
- Plain text: https://secwatch.observer/filing/0001213900-23-003597.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.